364 related articles for article (PubMed ID: 976601)
1. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD
J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
Coxe JS; O'Dorisio TM; Cataland S; Crockett SE
J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
[TBL] [Abstract][Full Text] [Related]
6. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
[TBL] [Abstract][Full Text] [Related]
7. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
8. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.
Crockett SE; Cataland S; Falko JM; Mazzaferri EL
J Clin Endocrinol Metab; 1976 Jun; 42(6):1098-103. PubMed ID: 932174
[TBL] [Abstract][Full Text] [Related]
9. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
Ebert R; Arnold R; Creutzfeldt W
Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
[TBL] [Abstract][Full Text] [Related]
10. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
11. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
12. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
Ross SA; Dupre J
Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
[TBL] [Abstract][Full Text] [Related]
13. Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes.
Talaulicar M; Ebert R; Willms B; Creutzfeldt W
Clin Endocrinol (Oxf); 1981 Feb; 14(2):175-80. PubMed ID: 7021006
[TBL] [Abstract][Full Text] [Related]
14. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
15. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.
Falko JM; Crockett SE; Cataland S; Mazzaferri EL
J Clin Endocrinol Metab; 1975 Aug; 41(2):260-5. PubMed ID: 1159045
[TBL] [Abstract][Full Text] [Related]
16. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
18. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
19. [Gastric inhibitory polypeptide (GIP) (author's transl].
Ebert R; Finke U
Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
[TBL] [Abstract][Full Text] [Related]
20. Effects of diet on insulin and gastric inhibitory polypeptide levels in obese children.
Deschamps I; Heptner W; Desjeux JF; Baltakse V; Machinot S; Lestradet H
Pediatr Res; 1980 Apr; 14(4 Pt 1):300-3. PubMed ID: 6990366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]